itraconazole has been researched along with carbostyril in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalton, LM; McBain, J; Reidarson, TH | 1 |
Brockus, CW; Currin, MP; Greene, CE; Jones, CJ | 1 |
Afeltra, J; de Hoog, GS; Rijs, AJ; Verweij, PE; Vitale, RG | 1 |
Azuma, J; Fukuda, T; Inaba, A; Koue, T; Kubo, M; Maune, H; Takeda, H | 1 |
Azuma, J; Fukuda, T; Funaki, T; Hashimoto, Y; Kayano, Y; Koue, T; Kubo, M; Takaai, M | 1 |
Harrison, MJ; Khan, KA; Murphy, DM; O'Callaghan, G; Plant, BJ; Ronan, NJ | 1 |
6 other study(ies) available for itraconazole and carbostyril
Article | Year |
---|---|
Lactate dehydrogenase isoenzyme patterns in cetaceans.
Topics: Alanine Transaminase; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Dolphins; Enrofloxacin; Female; Fluoroquinolones; Injections, Intramuscular; Isoenzymes; Itraconazole; Ketoconazole; L-Lactate Dehydrogenase; Liver; Male; Quinolones; Reference Values; Whales | 1999 |
Infection with Basidiobolus ranarum in two dogs.
Topics: Animals; Anti-Infective Agents; Antifungal Agents; Dog Diseases; Dogs; Enrofloxacin; Entomophthorales; Fatal Outcome; Female; Fluoroquinolones; Itraconazole; Liver; Quinolones; Treatment Outcome; Water Microbiology; Zygomycosis | 2002 |
In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Drug Combinations; Exophiala; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Quinolones; Sulfadiazine | 2003 |
Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.
Topics: Administration, Oral; Adult; Antifungal Agents; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Genotype; Humans; Itraconazole; Male; Piperazines; Quinolones | 2005 |
Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese males.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Bayes Theorem; Biological Availability; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Humans; Itraconazole; Japan; Male; Metabolic Clearance Rate; Models, Theoretical; Piperazines; Polymorphism, Genetic; Quinolones; Software; Tablets | 2007 |
Ivacaftor therapy in siblings with cystic fibrosis-the potential implications of Itraconazole in dosage and efficacy.
Topics: Adult; Aminophenols; Antifungal Agents; Cystic Fibrosis; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Inhibitors; Humans; Itraconazole; Male; Mutation; Quinolones; Siblings | 2015 |